L.R.G. Castor et al. / Free Radical Biology & Medicine 48 (2010) 1636–1643
1643
References
cells through PI3K inhibition and decreases angiogenesis in vivo. J. Agric. Food
Chem. 57:3055–3063; 2009.
[1] Babior, B. M. NADPH oxidase. Curr. Opin. Immunol. 16:42–47; 2004.
[2] Ushio-Fukai, M.; Nakamura, Y. Reactive oxygen species and angiogenesis: NADPH
oxidase as target for cancer therapy. Cancer Lett. 266:37–52; 2008.
[3] Kamata, T. Roles of Nox1 and other Nox isoforms in cancer development. Cancer
Sci. 100:1382–1388; 2009.
[23] Yang, H. L.; Chen, S. C.; Chang, N. W.; Chang, J. M.; Lee, M. L.; Tsai, P. C.; Fu, H. H.;
Kao, W. W.; Chiang, H. C.; Wang, H. H.; Hseu, Y. C. Protection from oxidative
damage using Bidens pilosa extracts in normal human erythrocytes. Food Chem.
Toxicol. 44:1513–1521; 2006.
[24] Kand'ár, R.; Záková, P.; Lotková, H.; Kucera, O.; Cervinková, Z. Determination
of reduced and oxidized glutathione in biological samples using liquid chroma-
tography with fluorimetric detection. J. Pharm. Biomed. Anal. 43:1382–1387;
2007.
[25] Hissin, P. J.; Hilf, R. A fluorometric method for determination of oxidized and
reduced glutathione in tissues. Anal. Biochem. 74:214–226; 1976.
[26] Van der Plancken, I.; Van Loey, A.; Hendrickx, M. E. Changes in sulfhydryl content
of egg white proteins due to heat and pressure treatment. J. Agric. Food. Chem. 53:
5726–5733; 2005.
[27] Galati, G.; Sabzevari, O.; Wilson, J. X.; O'Brien, P. J. Prooxidant activity and cellular
effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics.
Toxicology 177:91–104; 2002.
[4] Violi, F.; Basili, S.; Nigro, C.; Pignatelli, P. Role of NADPH oxidase in atherosclerosis.
Future Cardiol. 5:83–92; 2009.
[5] Calo, L. A.; Davis, P. A.; Pagnin, E.; Semplicini, A.; Pessina, A. C. NADPH oxidase
superoxide overproduction and nitric oxide bioavailability in essential hyperten-
sion. J. Hypertens. 23:665–666; 2005.
[6] Wilkinson, B. L.; Landreth, G. E. The microglial NADPH oxidase complex as a source
of oxidative stress in Alzheimer's disease. J. Neuroinflammation. 3:30–42; 2006.
[7] Trachootham, D.; Lu, W.; Ogasawara, M. A.; Nilsa, R. D.; Huang, P. Redox regulation
of cell survival. Antioxid. Redox Signal. 10:1343–1374; 2008.
[8] Bonomini, F.; Tengattini, S.; Fabiano, A.; Bianchi, R.; Rezzani, R. Atherosclerosis
and oxidative stress. Histol. Histopathol. 23:381–390; 2008.
[9] Brown, D. I.; Griendling, K. K. Nox proteins in signal transduction. Free Radic. Biol.
Med. 47:1239–1253; 2009.
[10] Muzaffar, S.; Shukla, N.; Jeremy, J. Y. Nicotinamide adenine dinucleotide
phosphate oxidase: a promiscuous therapeutic target for cardiovascular drugs?
Trends Cardiovasc. Med. 15:278–282; 2005.
[28] Núñez Delicado, E.; Sánchez Ferrer, A.; García Carmona, F. A kinetic study of the
one-electron oxidation of Trolox C by the hydroperoxidase activity of lipoxygen-
ase. Biochim. Biophys. Acta 1335:127–134; 1997.
[29] dos Santos, F. J.; Ximenes, V. F.; da Fonseca, L. M.; de Faria Oliveira, O. M.; Brunetti,
I. L. Horseradish peroxidase-catalyzed oxidation of rifampicin: reaction rate
enhancement by co-oxidation with anti-inflammatory drugs. Biol. Pharm. Bull. 28:
1822–1826; 2005.
[11] Stefanska, J.; Pawliczak, R. Apocynin: molecular aptitudes. Mediators Inflamm.,
[12] Barbieri, S. S.; Cavalca, V.; Eligini, S.; Brambilla, M.; Caiani, A.; Tremoli, E.; Colli, S.
Apocynin prevents cyclooxygenase 2 expression in human monocytes through
NADPH oxidase and glutathione redox-dependent mechanisms. Free. Radic. Biol.
Med. 37:156–165; 2004.
[13] Simons, J. M.; Hart, B. A. Ip Vai Ching, T.R.; Van Dijk, H.; Labadie, R.P. Metabolic
activation of natural phenols into selective oxidative burst agonists by activated
human neutrophils. Free Radic. Biol. Med. 8:251–258; 1990.
[14] Johnson, D. K.; Schillinger, K. J.; Kwait, D. M.; Hughes, C. V.; McNamara, E. J.; Ishmael,
F.; O'Donnell, R. W.; Chang, M. M.; Hogg, M. G.; Dordick, J. S.; Santhanam, L.; Ziegler, L.
M.; Holland, J. A. Inhibition of NADPHoxidase activation in endothelial cells by ortho-
methoxy-substituted catechols. Endothelium 9:191–203; 2002.
[15] Mora-Pale, M.; Weïwer, M.; Yu, J.; Linhardt, R. J.; Dordick, J. S. Inhibition of human
vascular NADPH oxidase by apocynin derived oligophenols. Bioorg. Med. Chem. 17:
5146–5152; 2009.
[30] Campos, A. M.; Sotomayor, C. P.; Pino, E.; Lissi, E. A pyranine based procedure for
evaluation of the total antioxidant potential (TRAP) of polyphenols. A comparison
with closely related methodologies. Biol. Res. 37:287–292; 2004.
[31] March, J. Advanced Organic Chemistry. John Wiley & Sons, New York; 1992.
[32] Beltrána, J. L.; Sanlib, N.; Fonrodonaa, G.; Barróna, D.; Özkanb, G.; Barbosa, J.
Spectrophotometric, potentiometric and chromatographic pKa values of polyphe-
nolic acids in water and acetonitrile–water media. Anal. Chim. Acta 484:l253–l264;
2003.
[33] Zhu, X. P.; Shi, S. Y.; Wei, J. J.; Lv, F. X.; Zhao, H. Z.; Kong, J. T.; He, Q.; Ni, J. R.
Electrochemical oxidation characteristics of p-substituted phenols using a boron-
doped diamond electrode. Environ. Sci. Technol. 41:6541–6546; 2007.
[34] Pichorner, H.; Metodiewa, D.; Winterbourn, C. C. Generation of superoxide and
tyrosine peroxide as a result of tyrosyl radical scavenging by glutathione. Arch.
Biochem. Biophys. 323:429–437; 1995.
[16] Ximenes, V. F.; Kanegae, M. P.; Rissato, S. R.; Galhiane, M. S. The oxidation of
apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition.
Arch. Biochem. Biophys. 457:134–141; 2007.
[17] Schlüter, T.; Steinbach, A. C.; Steffen, A.; Rettig, R.; Grisk, O. Apocynin-induced
vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
Cardiovasc. Res. 80:271–279; 2008.
[35] Robaszkiewicz, A.; Balcerczyk, A.; Bartosz, G. Antioxidative and prooxidative
effects of quercetin on A549 cells. Cell Biol. Int. 31:1245–1250; 2007.
[36] Sandur, S. K.; Ichikawa, H.; Pandey, M. K.; Kunnumakkara, A. B.; Sung, B.; Sethi, G.;
Aggarwal, B. B. Role of pro-oxidants and antioxidants in the anti-inflammatory
and apoptotic effects of curcumin (diferuloylmethane). Free Radic. Biol. Med. 43:
568–580; 2007.
[18] Heumüller, S.; Wind, S.; Barbosa-Sicard, E.; Schmidt, H. H.; Busse, R. Schröder K,
Brandes, R.P. Apocynin is not an inhibitor of vascular NADPH oxidases but an
antioxidant. Hypertension 51:211–217; 2008.
[19] Riganti, C.; Costamagna, C.; Bosia, A.; Ghigo, D. The NADPH oxidase inhibitor
apocynin (acetovanillone) induces oxidative stress. Toxicol. Appl. Pharmacol. 212:
179–187; 2006.
[20] Vejrazka, M.; Mícek, R.; Stípek, S. Apocynin inhibits NADPH oxidase in phagocytes
but stimulates ROS production in non-phagocytic cells. Biochim. Biophys. Acta.
1722:143–177; 2005.
[37] Bhat, S. H.; Azmi, A. S.; Hadi, S. M. Prooxidant DNA breakage induced by caffeic acid
in human peripheral lymphocytes: involvement of endogenous copper and a
putative mechanism for anticancer properties. Toxicol. Appl. Pharmacol. 218:
249–255; 2006.
[38] Simić, A.; Manojlović, D.; Segan, D.; Todorović, M. Electrochemical behavior and
antioxidant and prooxidant activity of natural phenolics. Molecules 12:2327–2340;
2007.
[39] Jones, D. P. Extracellular redox state: refining the definition of oxidative stress in
aging. Rejuvenation Res. 9:169–1681; 2006.
[21] Pan, J. S.; Hong, M. Z.; Ren, J. L. Reactive oxygen species: a double-edged sword in
oncogenesis. World J. Gastroenterol. 15:1702–1707; 2009.
[22] Lirdprapamongkol, K.; Kramb, J. P.; Suthiphongchai, T.; Surarit, R.; Srisomsap, C.;
Dannhardt, G.; Svasti, J. Vanillin suppresses metastatic potential of human cancer
[40] Van den Worm, E.; Beukelman, C. J.; Van den Berg, A. J.; Kroes, B. H.; Labadie, R. P.;
Van Dijk, H. Effects of methoxylation of apocynin and analogs on the inhibition of
reactive oxygen species production by stimulated human neutrophils. Eur. J.
Pharmacol. 433:225–230; 2001.